CD4 and neoplasm: The inhibition of FXR by norcholic acid upregulates PD-L1 on the surfaces of HCC cells and tumor-derived exosomes, which dramatically dampens the function of CD4+ T cells, resulting in an immunosuppressive tumor microenvironment [163].